Madeleine Albright, First Female Secretary of State and ‘Courageous Woman,’ Dies of Cancer

Article

Madeleine Albright, the first female secretary of state, died of cancer earlier today. She was 84 years old.

Madeleine K. Albright, the first female U.S. secretary of state nominated by former President Bill Clinton, died of cancer today at age 84.

In a statement posted on Albright’s Twitter account, her family said, “We are heartbroken to announce that Dr. Madeleine K. Albright, the 64th U.S. Secretary of State and the first woman to hold that position, passed away earlier today. The cause was cancer. She was surrounded by family and friends. We have lost a loving mother, grandmother, sister, aunt and friend.”

Former secretary of state Madeleine Albright. Photo credit: CBS via Getty Images

Former secretary of state Madeleine Albright. Photo credit: CBS via Getty Images

Albright was born in Prague, Czech Republic, with the name Marie Jana Korbelova in 1937 and came to the United States as a refugee in 1948. She was a “tireless champion of democracy and human rights,” her family wrote in the statement, and worked in the White House during former President Jimmy Carter’s administration. She then served as a foreign policy adviser to multiple presidential and vice-presidential candidates.

In 1993, former President Bill Clinton appointed Albright as the ambassador to the United Nations. Later, in 1997, she became secretary of state – and was the first woman to hold that position. In 2012, former President Barack Obama awarded Albright the Presidential Medal of Freedom, stating that her, “toughness helped bring peace to the Balkans and paved the way for progress in some of the most unstable corners of the world.”

More recently, Albright penned an op-ed in The New York Times saying that it would be a “historic error” for Russia’s Vladimir Putin to invade Ukraine.

At the time of her death, Albright was the chairwoman of the National Democratic Institute for International Affairs in Washington, D.C., and taught at Georgetown University.

Minnesota Senator Amy Klobuchar – who was also previously diagnosed with cancer – shared a tribute to Albright on Twitter. She wrote, “It is impossible to fully capture Madeleine Albright's influence and impact on the world. It is because of courageous women like her that we’ve made so much progress, and so much more is possible. This loss is immeasurable. John and I are keeping her family in our prayers.”

New York Senator Kirsten Gillibrand echoed Klobuchar’s sentiments. “Madeleine Albright never forgot what it was like to be welcomed to the U.S. as a refugee when she was just 11 years old. She spent the rest of her life fighting for democracy, human rights and for fellow refugees to be welcomed to this country like she was. May she rest in peace.”

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content